Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,158 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07059871Recruiting
Silkworm powder for nutrition in Alzheimer's disease
This trial tests whether a dietary supplement made from silkworm pupa powder can improve nutrition in people with Alzheimer's disease. It looks at weight, nutrition risk, and daily living skills over time.
Hangzhou, ZhejiangAges 50–90 - NCT07063576RecruitingPhase 2/Phase 3
Baclofen for persistent heartburn or regurgitation
This trial tests whether the drug baclofen can help patients who still have acid reflux symptoms (heartburn or regurgitation) despite taking standard treatments like PPIs for 8 weeks. If you've tried PPIs and still have symptoms, this may be an option.
DhakaAges 18 years+ - NCT07059546Recruiting
Studying sensitivity to adrenomedullin in chronic post-traumatic headache
This trial tests whether people with long-term headache after a mild head injury have an abnormal reaction to a substance called adrenomedullin, which may play a role in causing headaches. You will receive adrenomedullin and a placebo in separate sessions to see how your headache responds.
Glostrup MunicipalityAges 18–65 - NCT07063732Recruiting
Ketone drink, high altitude, and brain blood flow during exercise
This trial tests whether a ketone monoester supplement affects brain blood flow and exercise performance at high altitude. It may help us understand how to support brain function during altitude exposure.
Bishop, CaliforniaAges 18–35 - NCT07063095RecruitingPhase 3
Testing two antibiotics combined for serious bacterial infections
This study tests whether combining two antibiotics (ceftazidime and fosfomycin) works better than ceftazidime alone for hospitalized adults with serious bacterial infections. If you have a severe infection thought to be caused by Gram-negative bacteria, this trial may offer a new treatment option.
Geneva, Canton of GenevaAges 18 years+ - NCT07056699RecruitingPhase 3
Study on diabetes drugs and ketone production in type 1 diabetes
This trial tests how two diabetes medications, SGLT2i and pioglitazone, affect ketone production in people with type 1 diabetes. It aims to find new ways to improve blood sugar control.
San Antonio, TexasAges 18 years+ - NCT07063862RecruitingPhase 3
Psychedelic microdose for emotional distress in advanced illness
This trial tests whether very low doses of psilocybin (a psychedelic substance) can help reduce emotional distress in people with a life-limiting illness. If you are receiving palliative care and feeling anxious or depressed, this study might offer a way to explore a new treatment option.
Brampton, OntarioAges 18 years+ - NCT07064291Recruiting
Self-esteem support for people with multiple sclerosis
This trial tests a technique that uses word associations to help boost self-esteem in people with multiple sclerosis. If you have low self-esteem and are on oral MS treatment, this study might help you feel better about yourself.
GrenobleAges 18 years+ - NCT05035342RecruitingPhase 3
Fecal transplant to clear resistant gut bacteria
This Phase 3 study tests whether a fecal microbiota transplant (FMT) can eliminate hard-to-treat bacteria in the gut, such as ESBL or carbapenem-resistant bacteria. If it works, it may reduce future infections and antibiotic-resistant illness.
ClichyAges 18–105 - NCT06906081RecruitingPhase 2
Finerenone for diabetic nerve damage (FibroCAN study)
This trial tests if finerenone can help people with type 2 diabetes who have early signs of nerve damage affecting their heart and blood vessels (cardiovascular autonomic neuropathy). It aims to see if the drug can improve heart rate control and reduce symptoms.
GistrupAges 40 years+ - NCT06989697RecruitingPhase 3
Cilostazol and ginkgo for memory in older adults with diabetes
This trial tests whether a combination of cilostazol (a blood flow medication) and ginkgo (a herbal supplement) can help protect memory and thinking skills in people over 60 with type 2 diabetes. You may join if your memory is slightly below normal but not severely impaired.
Seongnam-siAges 60 years+ - NCT06988670RecruitingPhase 2
Testing EXT608 for adults with hypoparathyroidism
This trial tests a new medicine called EXT608 for adults with hypoparathyroidism. It aims to see if this medicine can help manage calcium levels better than current treatments.
Buenos Aires, Buenos Aires F.D.Ages 18–65 - NCT07046819RecruitingPhase 2
Tirzepatide for liver disease linked to alcohol use
This trial tests if tirzepatide, a medication that helps with weight and blood sugar, can improve liver health in people with alcohol use disorder who also have fatty liver disease. It aims to reduce liver fat and related risks.
Bethesda, MarylandAges 21–100 - NCT07047612RecruitingPhase 2/Phase 3
A study of ICP-332 for people with non-segmental vitiligo
This trial tests an investigational drug called ICP-332 for vitiligo that isn't limited to one area (non-segmental). It aims to see if the drug can help restore skin color. The study is for both adults and teenagers who have had vitiligo for at least 3 months with a certain amount of skin affected.
Wuhu, AnhuiAges 12–75 - NCT07054515RecruitingPhase 3
Study of oral nizubaglustat for rare genetic disorders
This trial tests a new oral medicine, nizubaglustat (AZ-3102), for children and adults (4+) with late-infantile or juvenile Niemann-Pick type C, GM1, or GM2 gangliosidosis. It aims to see if the drug is safe and helps slow disease progression.
Oakland, CaliforniaAges 4 years+ - NCT07049159RecruitingPhase 2
Testing a new oral vaccine to prevent shigella and ETEC infection
This trial tests an oral vaccine designed to protect against two common causes of severe diarrhea: shigella and ETEC bacteria. Healthy adults aged 18 to 50 will receive the vaccine and later be exposed to the bacteria to see if it works.
Baltimore, MarylandAges 18–50 - NCT07047690RecruitingPhase 2
Nemolizumab for adults with scleroderma
This study tests an investigational drug called nemolizumab for adults with systemic sclerosis (scleroderma). It aims to see if the drug can help reduce skin thickening and other symptoms, especially in people with early or moderate disease.
Ann Arbor, MichiganAges 18 years+ - NCT07051629RecruitingPhase 1
Testing a new epilepsy medicine for safety in healthy people and patients
This study tests a new medicine called SIF001 for safety. It first gives the medicine to healthy volunteers, and then to people with epilepsy who have seizures even while on their current medicines. The goal is to find a safe dose.
Tucson, ArizonaAges 18–70 - NCT07046559RecruitingPhase 1
Testing a new drug's safety in healthy volunteers
This trial is testing an experimental drug called LY4066708 in healthy people to see how safe it is and how the body processes it. It may help researchers understand if the drug can be used in future studies for conditions like Alzheimer's disease.
Holbeck, LeedsAges 18–65 - NCT07051603RecruitingPhase 1
Safety study of SAL0140 in healthy Chinese adults
This study tests the safety and how the body handles a new medicine (SAL0140) in healthy people. It helps doctors find the right dose and check for side effects.
Guangzhou, GuangdongAges 18–65 - NCT07048860Recruiting
Pilot study: intense exercise and coaching for older adults with weight and memory concerns
This pilot study tests a program to help older adults who are overweight, sedentary, and have mild memory changes. The goal is to see if intense, supervised physical activity and lifestyle coaching can improve mobility and thinking.
ToulouseAges 65–85 - NCT07054216Recruiting
Probiotic study for healthy newborns
This study tests whether giving a probiotic to infants can help their health. It involves pregnant people who plan to breastfeed and give birth at a specific hospital.
Hvidovre, Region SjællandAges birth–1 day - NCT07046572Recruiting
Pain relief for IUD insertion or endometrial biopsy
This trial tests if a pain-relief medication called methoxyflurane can help women who haven't had children before feel less pain during IUD insertion or a uterine biopsy. If you're getting one of these procedures and are not currently breastfeeding or using strong painkillers, this study might be for you.
Toronto, OntarioAges 18–65 - NCT07052799RecruitingPhase 3
Should you pause aspirin before a colonoscopy?
This trial compares stopping aspirin versus continuing it before a colonoscopy in people who take aspirin to prevent heart problems. The goal is to find out which approach is safer and works best.
Hong KongAges 18 years+
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,158 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.